Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade
M. Pinho-Schwermann, C. Purcell, L. Carlsen, K. E. Huntington, P. R. Srinivasan, A. George, V. Tajiknia, W. MacDonald, L. Zhou, L. Zhang, A. De Souza, H. P. Safran, B. A. Carneiro, W. S. El-Deiry
This study shows that androgen receptor inhibitors enhance NK cell-mediated killing of prostate cancer cells and sensitivity to NKG2A checkpoint blockade by upregulating HLA-E expression.
bioRxiv · Nov 15, 2023 · PreprintCancer Biology